Insider Transactions in Q1 2021 at Organicell Regenerative Medicine, Inc. (OCEL)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+0.61%
|
-
|
|
Feb 22
2021
|
Michael Carbonara Director |
BUY
Open market or private purchase
|
Direct |
1,818,181
+3.66%
|
$0
$0.06 P/Share
|
|
Feb 10
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.33%
|
-
|
|
Feb 10
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.83%
|
-
|
|
Feb 10
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+2.96%
|
-
|
|
Feb 10
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.21%
|
-
|
|
Jan 27
2021
|
Ian T Bothwell Interim CEO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.44%
|
-
|
|
Jan 27
2021
|
George Craig Shapiro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+1.86%
|
-
|
|
Jan 27
2021
|
Albert Mitrani Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+3.05%
|
-
|
|
Jan 27
2021
|
Maria Ines Mitrani Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000,000
+4.39%
|
-
|